In Depth 14 Mar 2025
Can GLP-1 agonists help treat addiction?
Discover how researchers have been exploring the potential of GLP-1 drugs for treating addiction disorders.
In Depth
- Latest Posts
In Depth 12 Mar 2025
Checkpoint inhibitors in cancer: breakthroughs, setbacks, and what’s next
Checkpoint inhibitors are drugs that harness the immune system to destroy cancer cells. Let us review what’s been going on in the field.
In Depth 11 Mar 2025
The gender gap in clinical trials: Why women are still underrepresented
Find out what led biotech to a situation where women are underrepresented in clinical trials and how the industry is correcting it.
In Depth 7 Mar 2025
Catalonia: A biotech hub going from strength to strength, with Barcelona at its core
Take a deeper look at Catalonia’s biotech sector and overall life sciences hub, including the key drivers behind its success.
In Depth 4 Mar 2025
The biggest biotech funding rounds in February 2025
The companies Eikon Therapeutics, Sionna Therapeutics, and Abcuro bagged the biggest biotech funding rounds overall in February 2025.
In Depth 26 Feb 2025
New non-opioid pain medication: How is the biotech industry fighting pain after the opioid crisis?
Find out how biotechs are fighting pain with new non-opioid pain medication, as they look to overcome the ongoing opioid crisis.
ADVERTISEMENT
ADVERTISEMENT
In Depth 21 Feb 2025
The future of organ transplants: Xenotransplantation, 3D bioprinting and stem cells
Discover how biotech could solve the organ shortage crisis through xenotransplantation, 3D bioprinting and stem cells.
In Depth 18 Feb 2025
T cell engagers: A promising, fast-growing field for cancer and autoimmune disease treatments
T cell engagers represent a novel approach to tuning the immune system to target and kill tumor cells, expanding treatment options for cancer.
In Depth 17 Feb 2025
Biotech’s legal storm: Why securities class action lawsuits are surging
Find out about what’s behind the increase of securities class action lawsuits in the biotech industry and how to prevent them.
In Depth 12 Feb 2025
Dendritic cell therapy: Diakonos, Northwest Biotherapeutics and Mendus push ahead with next-generation candidates
Find out about the field of dendritic cell therapy, as several companies attempt to bring next-generation candidates through the clinic.
In Depth 10 Feb 2025
Monoclonal antibodies: are they the key to treating Alzheimer’s disease?
A major stride in treating Alzheimer’s disease has been the development of monoclonal antibodies.
In Depth 5 Feb 2025
Needle-free vaccines: Micron Biomedical, Vaxxas, and IntegriMedical bring their new technologies to patients
Discover the advantages of needle-free vaccines and which companies are developing their own promising delivery solutions in this space.
ADVERTISEMENT
